Bayer could benefit from home advantage in St. Louis Roundup cancer trial: experts
ST. LOUIS (Reuters) - Bayer AG (BAYGn.DE), facing an upcoming trial in St. Louis over allegations that its Roundup weed killer causes cancer, has recruited Missouri-based expert witnesses to make its case in a place where it has century-old roots but where ju…
bubmagJuly 22, 2019